Chitosan Nanoparticles as Oral Drug Carriers

被引:37
|
作者
Rodrigo Guadarrama-Escobar, Omar [1 ]
Serrano-Castaneda, Pablo [1 ]
Anguiano-Almazan, Ericka [1 ]
Vazquez-Duran, Alma [2 ]
Concepcion Pena-Juarez, Ma. [1 ]
Vera-Graziano, Ricardo [3 ]
Isabel Morales-Florido, Miriam [1 ,4 ]
Rodriguez-Perez, Betsabe [5 ]
Marlen Rodriguez-Cruz, Isabel [6 ]
Esteban Miranda-Calderon, Jorge [4 ]
Juan Escobar-Chavez, Jose [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria Lab 12, Carretera Cuautitlan Teoloyucan,Km 2-5 San Sebast, Cuautitlan 54714, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria L14 Ciencia & Te, Mexico City 54714, Estado de Mexic, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Invest Mat, Apartado Postal 70-360, Mexico City 04510, Mexico
[4] Univ Autonoma Metropolitana, Dept Sistemas Biol, Lab Farm Mol & Liberac Controlada, Xochimilco 04960, Mexico
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Lab Serv Anal Propoleos LASAP, Unidad Invest Multidisciplinaria UIM, Cuautitlan 54714, Mexico
[6] Hosp Reg Alta Especial Zumpango, Unidad Ensenanza & Invest, Carretera Zumpango Jilotzingo 400,2a Secc, Zumpango 55600, Mexico
关键词
chitosan; chitosan nanoparticles; oral administration; IN-VITRO; POLYMERIC NANOPARTICLES; GOLD NANOPARTICLES; DELIVERY; RELEASE; CANCER; BIOAVAILABILITY; PEPTIDES; TOXICITY; SYSTEM;
D O I
10.3390/ijms24054289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of nanoparticles as drug delivery systems has increased in importance in the last decades. Despite the disadvantages of difficulty swallowing, gastric irritation, low solubility, and poor bioavailability, oral administration stands out as the most widely used route for therapeutic treatments, though it may not always be the most effective route. The effect of the first hepatic pass is one of the primary challenges that drugs must overcome to carry out their therapeutic effect. For these reasons, controlled-release systems based on nanoparticles synthesized from biodegradable natural polymers have been reported to be very efficient in enhancing oral delivery in multiple studies. Chitosan has been shown to have an extensive variability of properties and roles in the pharmaceutical and health fields; of its most important properties are the ability to encapsulate and transport drugs within the body and enhance the drug interaction with the target cells, which improves the efficacy of the encapsulated drugs. The physicochemical properties of chitosan give it the ability to form nanoparticles through multiple mechanisms, which will be addressed in this article. The present review article focuses on highlighting the applications of chitosan nanoparticles for oral drug delivery.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Chitosan in Oral Drug Delivery Formulations: A Review
    Sangnim, Tanikan
    Dheer, Divya
    Jangra, Nitin
    Huanbutta, Kampanart
    Puri, Vivek
    Sharma, Ameya
    PHARMACEUTICS, 2023, 15 (09)
  • [32] Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery
    Jana, Sougata
    Maji, Nirmal
    Nayak, Amit Kumar
    Sen, Kalyan Kumar
    Basu, Sanat Kumar
    CARBOHYDRATE POLYMERS, 2013, 98 (01) : 870 - 876
  • [33] Drug Loading in Chitosan-Based Nanoparticles
    Herdiana, Yedi
    Febrina, Ellin
    Nurhasanah, Siti
    Gozali, Dolih
    Elamin, Khaled M.
    Wathoni, Nasrul
    PHARMACEUTICS, 2024, 16 (08)
  • [34] Preparation of PEG-grafted chitosan nanoparticles as peptide drug carriers
    Ohya, Y
    Cai, R
    Nishizawa, H
    Hara, K
    Ouchi, T
    STP PHARMA SCIENCES, 2000, 10 (01): : 77 - 82
  • [35] Recent development of micro-nano carriers for oral antineoplastic drug delivery
    Li, Hongzheng
    Chen, Xiang
    Rao, Shangrui
    Zhou, Minyu
    Lu, Jianhua
    Liang, Danna
    Zhu, Bingzi
    Meng, Letian
    Lin, Ji
    Ding, Xiaoya
    Zhang, Qingfei
    Hu, Danhong
    MATERIALS TODAY BIO, 2025, 30
  • [36] Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers
    He, Miao
    Zhao, Ziming
    Yin, Lichen
    Tang, Cui
    Yin, Chunhua
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 373 (1-2) : 165 - 173
  • [37] Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery
    Pawar, Harshavardhan
    Douroumis, Dionysios
    Boateng, Joshua S.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 90 : 102 - 108
  • [38] Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid
    de Lima, Isabela Angeli
    Khalil, Najeh Maissar
    Tominaga, Tania Toyomi
    Lechanteur, Anna
    Sarmento, Bruno
    Mainardes, Rubiana Mara
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 993 - 1002
  • [39] Enhancement of oral bioavailability of celastrol by chitosan microencapsulated porous starch carriers
    Wang, Jiangrui
    Liang, Xuewei
    Du, Yan
    Tang, Zhongjie
    Duan, Xuehui
    Sun, Zewei
    Zhao, Jianquan
    Xu, Wei
    Wang, Yingyi
    Tang, Yixuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 282
  • [40] Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers
    Wang, Xue
    Chen, Changjing
    Huo, Da
    Qian, Hanqing
    Ding, Yin
    Hu, Yong
    Jiang, Xiqun
    CARBOHYDRATE POLYMERS, 2012, 90 (01) : 361 - 369